Author: Press Trust Of India | Tuesday September 15, 2026
The therapy is approved for conditions, including metastatic non-small cell lung cancer, renal cell carcinoma, squamous cell carcinoma of the head and neck, melanoma, classical Hodgkin lymphoma, urothelial carcinoma, colorectal cancer, esophageal squamous cell carcinoma, gastric and gastroesophageal junction cancer.
www.ndtvprofit.com